Introduction
The tryptophan-rich sensory protein for oxygen (TSPO) receptor [1] or peripheral benzodiazepine receptor (PBR) is the most studied imaging biomarker for neuroinflammation as it is expressed on the outer mitochondrial membrane of microglia [2] . TSPO plays an important role in neurosteroidogenesis, more specifically in the transmembrane transport of cholesterol from the outer to the inner mitochondrial membrane, where the cleavage of the side chain by cytochrome p450 converts cholesterol into pregnenolone. This pregnenolone is an important precursor for cerebral steroids which play a crucial role in brain development and normal functioning during adulthood [2] . TSPO expression in the central nervous system is low under healthy circumstances. However, TSPO expression increases in Dieter Ory and Andrey Postnov were joint first authors.
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response to neuronal insults, mainly in microglia and astrocytes. This can be seen in several neurodegenerative diseases such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Huntington's disease and Alzheimer's disease (AD) [2, 3] .
The exact role of TSPO in regulation of neuroinflammation is not yet fully understood. Bae et al. [4] suggested that TSPO negatively regulates neuroinflammation in microglia by attenuating the activation of nuclear factor-kappaB and decreasing the production of proinflammatory cytokines. Since the amount of TSPO upregulation in response to injury is correlated with the degree of damage in neuroinflammation, TSPO has been identified as a valuable imaging biomarker for neuroinflammation [5] . [ 11 C]PK11195 has been the most used TSPO PET ligand since its introduction in the 1980s [6] . However, [ 11 C]PK11195 has several limitations such as a high level of nonspecific binding and poor signal-to-noise ratios which hamper its quantification. Consequently, new TSPO PET tracers have been designed [2] . One of these radioligands is [
18 F]DPA-714, developed by James et al. [7] . [ ]DPA-714 has been used in animal models of neuroinflammation [7] [8] [9] [10] , in healthy volunteers [11] , and in patients with AD [12] , stroke [13] and ALS [14] . However, kinetic modelling data on [ In the present study, we evaluated the quantification of neuroinflammation in rat brain using [ 18 F]DPA-714 smallanimal PET. We compared reference tissue models (RTM) with full kinetic modelling using metabolite-corrected arterial blood input for [ 18 F]DPA-714 quantification with the aim of determining whether arterial sampling would be needed in future studies for accurate quantification of [ 18 F]DPA-714 uptake in rodent brain or whether less-invasive approaches would be sufficient. A rat model of acute, local neuroinflammation induced by lipopolysaccharide (LPS) from gramnegative bacteria was used to evaluate the quantification. LPS activates Toll-like receptor 4 (TLR4) that is mainly expressed by macrophages and microglia. Activation of TLR4 induces signal transduction pathways that regulate diverse transcriptional and posttranscriptional processes involved in inflammation [15] . This animal model provides robust, acute and unilateral neuroinflammation, and could therefore be used for screening newly developed PET radiotracers as biomarkers for neuroinflammation and for the evaluation of antiinflammatory therapies using noninvasive imaging. 
Material and methods

Animals
Ten female Wistar rats (Charles River, France) were used in the experiments, with an average weight (± standard deviation) of 232±27 g at the start of the experiments. The animals were housed in groups of two at an average room temperature of 22°C and under a 12-h light/dark cycle. Food and water were available ad libitum.
To induce neuroinflammation, stereotactic surgery was performed 3 days prior to small-animal PET imaging. All surgical procedures were performed under ketamine (60 mg/kg) and medetomidine (0.4 mg/kg) anaesthesia administered intraperitoneally using aseptic procedures. All animals were positioned in a stereotactic head frame (Stoelting, Wood Dale, IL). A small hole was drilled in the skull at the appropriate location using Bregma as reference. Neuroinflammation was induced by injecting 50 μg of LPS (E. coli 055:B5; Sigma Aldrich, St. Louis, MO) in 4 μl of sterile 0.9 % NaCl solution into the right striatum at the following coordinates: 0.5 mm anteroposterior, 3 mm lateral, and 5.5/4.5 mm dorsoventral. After injection of 2 μl, the needle was retracted dorsoventrally for 1 mm and another 2 μl was injected. The needle was left in place for an additional 10 min before being slowly withdrawn from the brain. The contralateral side was injected with 4 μl of sterile 0.9 % NaCl solution using an identical procedure.
The research protocol was approved by the local Animal Ethics Committees (P223/2013) and was performed according to European Ethics Committee guidelines (decree 86/609/EEC).
Small-animal PET imaging
Imaging experiments were performed 3 days after LPS injection on a lutetium oxyorthosilicate detector-based tomograph (microPET FOCUS-220; Siemens Medical Solutions, Malvern, PA) which has a nominative transaxial resolution of 1.35 mm full-width at half-maximum. The final spatial resolution after rebinning and reconstruction using the specific reconstruction algorithm OSEM 3D followed by MAP was 1.5 mm. Data were acquired in a 128 × 128 × 95 matrix with a pixel width of 0.475 mm and a slice thickness of 0.796 mm. The coincidence window width was set at 6 ns.
During PET imaging, rats were kept under gas anaesthesia (2.5 % isoflurane in oxygen at 1 L/min flow rate), and their body temperature was maintained between 36 To further prevent possible effects of blood volume changes, 100 μL of saline was reinjected for the 90-min sample and all subsequent samples. This procedure was also helpful for flushing the cannula. All blood samples were immediately stored on ice to stop tracer metabolism. The plasma time-activity curve was corrected for the fraction of unchanged radioligand that was quantified using reverse-phase (RP) HPLC (LaChrom Elite HPLC system; Hitachi, Darmstadt, Germany; Chromolith C18, 3 mm×100 mm; Merck, MA). Plasma samples were isolated from whole blood from six animals by centrifugation at 3,000 rpm for 5 min and spiked with standard DPA-714 (20 μg) prior to HPLC analysis The HPLC separation was achieved with gradient mixtures of 0.05 M sodium acetate (pH 5.5) (A) and CH 3 CN (B) (0 -4 min, 100 % A, flow rate 0.5 mL/min; 4.0 -4.1 min, 100 % A, flow rate 1 mL/min; and 4.1 -14 min, linear gradient from 100 % A to 10 % A, flow rate 1.0 mL/min; 14 -17 min, 10 % A, flow rate 1 mL/min; 17 -25 min, 100 % B, flow rate 0.5 mL/min). The HPLC eluate was collected every minute after passing through an inline ultraviolet detector (254 nm), with the exception of every 15 s from 1 min before to 1 min after elution of the intact tracer. Radioactivity in all fractions was measured using an automated γ-counter equipped with a 7.62-cm NaI(TI) well crystal coupled to a multichannel analyser (1480 Wizard; Wallac, Turku, Finland). The results were corrected for background radiation and physical decay during counting. F]DPA-714 in perfused cerebrum and cerebellum of three female Wistar rats 3 days after LPS injection were quantified at 30 min after tracer injection following a previously described procedure [17] with the difference that the right and left cerebrum were separately evaluated. Brain homogenate extracts were analysed using an analytical XBridge column (C 18 , 5 μm, 3 mm×100 mm; Waters, Milford, MA) eluted with a mixture of 0.01 M ammonium acetate (pH 7) and acetonitrile (67.5/32.5 v/v) at a flow rate of 0.75 mL/min. UV detection was performed at 263 nm.
PET data analysis and kinetic modelling
All PET images were rigidly normalized to a custommade rat brain template in Paxinos stereotactic space that allowed the use of a predefined volume-of-interest map. The procedure for standardization and its validation have been described previously [18] . Time-activity curves for the contralateral (left) and ipsilateral (right) striatum, the contralateral and ipsilateral cortex, and the cerebellum were generated for kinetic modelling with PMOD software (version 3.4; PMOD Technologies, Zurich, Switzerland). Large volumes of interest were used to improve the signal-to-noise ratio [19] .
One-tissue (1T) and two-tissue (2T) compartment models, including 1T, 2T and 2T with a fixed nondisplaceable volume (V ND ) models, were considered to describe [ 18 F]DPA-714 kinetics in rat brain using a metabolite-corrected plasma input function. The consensus nomenclature according to Innis et al. [20] was used, where V T is the total distribution volume, including specific and nondisplaceable uptake, and BP ND is the nondisplaceable binding potential defined as the ratio between the distribution volumes of specific and nondisplaceable binding minus 1.
In modelling the data, a region-dependent (variable) blood volume parameter was taken into account. Though TSPO is known to be homogeneously expressed in healthy brain at low levels, we also evaluated different RTM and reference region candidates for future quantification without blood sampling. We investigated simplified RTM (SRTM), multilinear RTM (MRTM) [21, 22] , a two-tissue reference model [23] , and standardized uptake value ratios (SUVR) of a 10-min scan [24] . We used the cerebellum, contralateral (left) striatum and contralateral (left) cortex as potential reference regions. Regions on the contralateral side were chosen because the neuroinflammation remained within the same hemisphere although spread outside the injected striatum was observed (Fig. 1) .
The stability of BP ND over time using RTMs was investigated for acquisitions up to 60 min, using the value obtained from the complete 180-min dataset as the reference.
Statistical analysis
Values are reported as means±SD. Conventional statistical analysis was performed using GraphPad Prism v. 5.0 (San Diego, CA). Spearman's correlation analysis was used for all correlative tests. Bland-Altman plots were used to test the interchangeability of BP ND values calculated by different methods. Significance was defined at the 95 % probability level. Goodness-of-fit by nonlinear least squares analysis was evaluated using the Akaike information criterion (AIC).
Results
Brain kinetics
After injection of [ (Fig. 2a) . 
Plasma kinetics
Ex vivo radiometabolite analysis in rat brain
Radiometabolite concentrations were also quantified in rat brain tissue. The reconstructed radiochromatograms from the HPLC analysis of extracts of the right and left cerebrum and cerebellum obtained 30 min after tracer injection showed only one radioactive peak corresponding to intact [ 18 F]DPA-714 eluting at 9 min (chromatograms not shown). For all regions, the fractions of both the more polar and more lipophilic radiometabolites were negligible (<3 %). Recovery of the HPLC (XBridge) column-injected radioactivity was 96.0±2.1 % (mean from three animals).
Compartmental modelling of [
F]DPA-714 in rat brain
Compartmental modelling excluded the 1T model from consideration based on the AIC score. The visual quality of the 2T reversible model was also superior to that of the 1T model (Fig. 3) .
Focusing on the 2T reversible model for describing [ 18 F]DPA-714 brain kinetics, the utility of a fixed nondisplaceable distribution volume (2T, fixed V ND ) was also evaluated. Fixed V ND was determined using a general 2T model for the contralateral striatum, contralateral cortex and cerebellum, and subsequently used for other brain regions. The 2T fixed V ND model was not superior to the 2T model according to AIC, regardless of the brain region selected to predetermine the nondisplaceable distribution volume. At the same time, the nonrestricted 2T model resulted in slightly higher V T values (Table 1) . [ 18 F]DPA-714 V T values from the 2T model were 43.0±19.1 in the ipsilateral striatum, and were 36.1 ± 14.9, 37.1 ± 15.3, and 37.2±15.1 for the same region when fixing V ND to the value for the left striatum, cerebellum and left cortex, respectively (difference not significant, Table 1 ).
To assess the ability of simplified methods for quantifying tracer binding to TSPO in rats, SRTM and MRTM were evaluated against the 2T model as the gold standard using BP ND as the outcome parameter. BP ND of the 2T model using a (Fig. 4) . The contralateral cortex was rejected as a candidate for estimating V ND for this tracer, primarily due to BP ND underestimation and high bias (range −171.89 -−172.53 %). Interestingly, only when the contralateral striatum was used as the reference region in the SRTM and MRTM was an additional correlation observed between its BP ND values and the k 3 /k 4 of the 2T model (Spearman's r=1.0; p=0.0004), suggesting overall superiority of this region over the cerebellum as a potential reference region (Supplementary Fig. 1 ). An overview of all statistical comparisons for evaluating 'model/reference region' pairs is shown in Table 2 . Scatterplots and BlandAltman plots comparing SRTM and MRTM with both the contralateral striatum and cerebellum as the reference region are shown in Fig. 4 .
Subsequently taking the contralateral striatum as the reference region of choice, the SRTM underestimated BP ND While SRTM and MRTM assume a 1T model as an appropriate model for tracer kinetics of both target and reference region, a 2T model proved to be superior for modelling [ 18 F]DPA-714 kinetics. As a consequence, we also checked whether a more sophisticated reference tissue model, the 2T reversible model, would further improve BP ND estimation using a reference region. The 2T reversible model describes reference region kinetics as a 2T model and correlation analysis showed that it performed as well as the SRTM and MRTM (Spearman's r=0.94; p=0.003). It showed a smaller underestimation of BP ND (−11.75 %), but failed to converge in analysing the data from one animal. In addition, the SUVR method, based on areas under the curve, overestimated BP ND : SUVRs at 90, 120 and 180 min overestimated BP ND by 8.83±19.44 %, 11.01±19.95 % and 12.97±20.82 %, respectively. The values found with this method were also highly correlated with the BP ND values from the 2T model (Spearman' r > 0.89; p<0.05). However, Bland-Altman analysis of this method showed an unwanted trend towards a higher bias for longer time windows. To determine the minimal imaging time required for reliable estimation of BP ND , we gradually reduced the dynamic brain data acquisition duration from 0 -180 min to 0 -120 min, 0 -90 min and 0 -60 min. We assessed the stability over time of the BP ND estimates obtained using both SRTM and MRTM (Fig. 5) . The calculated BP ND values increased asymptotically when the acquisition duration was increased from 0 -60 to 0 -180 min. For an acquisition duration of 0 -90 min, the BP ND estimates obtained using SRTM and MRTM were 89 % and 90 % of the reference value, respectively.
Discussion
The aim of this study was to evaluate different quantification approaches for [ 18 F]DPA-714 uptake in rat brain injected with LPS. Four RTM were evaluated against full kinetic modelling using metabolite-corrected arterial blood input. In this way, the possibility was assessed of eliminating the need for arterial sampling in rats which would allow more straightforward serial [ 18 F]DPA-714 PET measurements over time. We studied the LPS rat model in which strong TSPO binding has previously been demonstrated [25] [26] [27] . In addition, we examined brain and plasma kinetics of [ 18 F]DPA-714, more particularly the radiometabolites present and the extent to which they pass the blood-brain barrier (BBB) with the potential to contribute to specific and/or nonspecific binding.
In plasma, two unidentified polar radiometabolite fractions were detected. The radiotracer appeared to be quite stable: at 40 min after injection, intact tracer represented 73±8 % of the radioactivity in plasma. In brain tissue, the observed fraction of [ 18 F]DPA-714 radiometabolites was negligible in whole cerebrum and cerebellum (<3 % of radiometabolites at 30 min after tracer injection), suggesting that this possible factor confounding the quantification of TSPO binding with PET does not need to be taken into account. This observation is also in line with results presented by Peyronneau et al. [28] , who showed that at 120 min after injection, about 85 % of the activity present in rat brain tissue is still due to intact [ 18 F]DPA-714. We also observed no difference in the radiometabolite fractions of cerebrum injected with LPS and saline, indicating a limited influence of possible BBB disruption. This was further supported by dynamic Gd-DOTA enhanced MRI in this model that showed BBB breakdown near the LPS injection site on day 1, that gradually recovered over time to be almost absent on day 3 after injection, i.e. also the timing of our [
18 F]DPA-714 PET imaging (unpublished findings; Supplementary Fig. 2 ). Of special interest was that the detected rate of metabolite formation in plasma was lower in our animal PET study than found in previous studies with [ 18 F]DPA-714 in rats [28] . This could be due to strain differences in metabolism [29] [30] [31] . An effect of LPS on the renal and hepatic clearance of drugs (e.g. metformin [32] ) is rather unlikely [33, 34] , as we injected the LPS stereotactically into the brain.
Among the kinetic models, the 1T model did not correctly represent [
18 F]DPA-714 kinetics. A 2T reversible model with metabolite-corrected plasma input was used as the gold standard to evaluate other arterial input models. Reducing the number of parameters from four in the 2T reversible model to three by fixing the V ND estimate for all brain regions did not result in lower AIC values, regardless of the brain region that was selected for estimating V ND . This could indicate that nondisplaceable binding cannot be considered as constant throughout the brain, although differences between V T estimates using a 2T model with fixed V ND and a nonrestricted 2T model were very limited. Therefore, the 2T reversible model with four parameters is recommended for quantifying [ 18 F]DPA-714 uptake in rat brain, and this is in line with [ 18 F]DPA-714 findings in humans [12] . Of the investigated RTM, both SRTM and MRTM using the contralateral striatum as the reference region performed best as shown by the correlative and Bland-Altman analyses. The two RTM showed comparable bias (about 18 -20 %), displayed similar 95 % limits of agreements and correlated well (Spearman's r=0.96 for both) with the BP ND given by the 2T model, indicating that they may be an alternative to the 2T model to avoid invasive arterial blood sampling. The reported 18 -20 % bias was probably a result of ignoring the activity in the blood pool as seen in SRTM, combined with the fact that the 2T model was required for describing tissue kinetics [35] .
SRTM and MRTM modelling presumes that the reference region is also devoid of receptors and the nondisplaceable binding is the same in the reference region as in other regions of interest. Unfortunately, expression of TSPO has been reported in healthy and pathologically affected areas of rodent brain [36] , albeit at low levels in healthy areas. In previous work, the contralateral striatum and cerebellum have been used [37] [38] [39] [40] as the reference regions for [ 18 F]DPA-714 quantification in rats and humans, but also cluster analysis has been performed by several groups [41] [42] [43] . Particularly in rats, (pre)blocking of TSPO to evaluate the correctness of a reference region has so far been unsuccessful [44] . In the present study we also evaluated the use of the contralateral (left) striatum, the cerebellum and the contralateral (left) cortex as reference regions against full kinetic modelling. The contralateral striatum was an obvious choice because the level of normal, noninflammatory expression of TSPO in the mirrored region would be expected to be the same as in the LPS-injected region. The drawback was its small size which in the rat brain leads to noisy time-activity curves. In order to overcome this problem, larger regions (the cerebellum and the contralateral (left) cortex) were selected to improve the signal-to-noise ratios.
Of all the reference regions evaluated, the results obtained using the contralateral striatum were superior to those obtained using the cerebellum and contralateral cortex. SRTM and MRTM BP ND values using the contralateral striatum not only correlated with BP ND values from the 2T model, but also with k 3 /k 4 , another parameter expressing binding potential and one that has been reported to have higher variability than V T /V ref − 1 [12, 45, 46] . Also, the use of the cerebellum as the reference region led to lower BP ND values in [ 18 F]DPA-714 quantification with greater variability in the Bland-Altman analysis, despite a nearly perfect correlation, overall suggesting a higher bias of specific binding in this region than in the contralateral striatum. Specific binding in the cerebellar area has also been reported around the ventricles in the brain of both the rat and monkey [5, 47] . This has also been seen using [ 123 I]-CLINDE to image TSPO in patients with stroke and glioblastoma [48] . The authors found that cerebellar V T values fall into categories determined by the three TSPO genotypes. In our work, the contralateral cortex was not a good candidate for defining V ND because of the high underestimation and high bias (range −171.89 -−172.53 %) probably due to partial volume effects of the relatively high TSPO binding in the harderian glands and bulbus olfactorius [49] .
The unilateral LPS injection model and the corresponding focal inflammation facilitated the choice of an appropriate reference region. However, for other models of neuroinflammation in which inflammation is less focal, the choice of an appropriate reference region needs careful consideration. Therefore, methodologies which have been developed for automatically extracting reference region input curves for human brain PET studies with (R)-[ 11 C]PK11195 should be considered for translation to the preclinical setting [41] . In this way, RTM could be applied without any presumption about the location of the brain inflammation and without relying on focal inflammation.
A reduction in scan time is desirable for experimental simplicity, for cost effectiveness and for reducing the effects of anaesthesia in diseased animals. Quantification of [ 18 F]DPA-714 binding as BP ND using SRTM and MRTM did not provide stable values with scans of less than 90 min duration. The more appropriate 2T RTM which is a 2T model for reference region kinetics did reduce the BP ND bias of SRTM and MRTM compared to the BP ND estimates with an unconstrained 2T model. However, the model failed in one animal, probably due to the fact that the tracer kinetics in that specific animal were close to 1T kinetics. Therefore, a 2T RTM is not considered the model of choice for quantifying [ SUVR quantification led to a systematic overestimation of TSPO binding compared to the BP ND values estimated with an unconstrained 2T model with the degree of overestimation increasing with later time windows. This bias is very similar to the bias observed with SUVR for the quantification of [ 11 C]-PIB brain PET data and may be caused by plasma clearance [50] . Therefore, SUVR cannot be considered as a good approximation of the distribution volume ratio.
From a methodological point of view, we believe that the 2T model used in this study to quantify TSPO binding in rats would also be the model of choice for assessing low-grade inflammation using [ 18 F]DPA-714 in other chronic rat models. In rat models of low-grade inflammation more noise in the target region would be expected, but this effect can be reduced by taking larger volumes of interest to improve the signal-to-noise ratio. However, whether [ [47] . One major advantage of their quinolinic acid model is that the activation process (microglial activation accompanied by a late progressive astrocytic reaction) progresses over several months, which enables the longitudinal analysis of each glial activation phase in vivo. Lavisse et al. found that changes in specific binding became statistically significant in the lesion only on day 21 (2.7-fold increase in V T ), associated with a 7.6-fold increase in TSPO optical density. They thus suggested that a relatively large change in TSPO density must occur in diseased brain in order to be detected in vivo by [ 
Conclusion
In conclusion, we successfully characterized the kinetics of [ 18 F]DPA-714 in rat brain. Two radiometabolite fractions are present in plasma, but there was no evidence suggesting that these cross the BBB. Full quantification of the binding the tracer to TSPO was possible using a 2T model. SRTM and MRTM with the contralateral striatum as the reference region are reasonable substitutes to avoid invasive arterial blood sampling provided that the acquisition time is at least 90 min.
